Paper24924752
Eculizumab treatment for rescue of renal function in IgA nephropathy.
Rosenblad T and 5 others. Pediatr Nephrol, 2014. Cited by 96 papers, by iCite.
Cite this record
ConductScience Library. Eculizumab treatment for rescue of renal function in IgA nephropathy. Papers, record 24924752. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/24924752
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antibodies, Monoclonal, Humanized | Major topic |
| Complement Inactivating Agents | Major topic |
| Glomerulonephritis, IGA | Major topic |
| Kidney | Major topic |
| Salvage Therapy | Major topic |
| Adolescent | |
| Biopsy | |
| Creatinine | |
| Glomerular Filtration Rate | |
| Humans | |
| Kidney Glomerulus | |
| Male | |
| Renal Insufficiency |
Source PubMed
References15
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 20734203 | IgA nephropathy associated with a novel N-terminal mutation in factor H. | Eur J Pediatr | 2011 | https://conductscience.org/library/papers/20734203 | PubMed |
| 2 | 19162324 | Is complement factor H a susceptibility factor for IgA nephropathy? | Mol Immunol | 2009 | https://conductscience.org/library/papers/19162324 | PubMed |
| 3 | 22111871 | Excretion of complement proteins and its activation marker C5b-9 in IgA nephropathy in relation to renal function. | BMC Nephrol | 2011 | https://conductscience.org/library/papers/22111871 | PubMed |
| 4 | 16687629 | Glomerular activation of the lectin pathway of complement in IgA nephropathy is associated with more severe renal disease. | J Am Soc Nephrol | 2006 | https://conductscience.org/library/papers/16687629 | PubMed |
| 5 | 22792353 | Decreased circulating C3 levels and mesangial C3 deposition predict renal outcome in patients with IgA nephropathy. | PLoS One | 2012 | https://conductscience.org/library/papers/22792353 | PubMed |
| 6 | 21399633 | Genome-wide association study identifies susceptibility loci for IgA nephropathy. | Nat Genet | 2011 | https://conductscience.org/library/papers/21399633 | PubMed |
| 7 | 3573542 | Complement membrane attack (MAC) in idiopathic IgA-glomerulonephritis. | Kidney Int | 1987 | https://conductscience.org/library/papers/3573542 | PubMed |
| 8 | 9264010 | Galactose-deficient IgA1 in sera of IgA nephropathy patients is present in complexes with IgG. | Kidney Int | 1997 | https://conductscience.org/library/papers/9264010 | PubMed |
| 9 | 19571791 | The Oxford classification of IgA nephropathy: rationale, clinicopathological correlations, and classification. | Kidney Int | 2009 | https://conductscience.org/library/papers/19571791 | PubMed |
| 10 | 23072577 | Pathogenesis of immunoglobulin A nephropathy: recent insight from genetic studies. | Annu Rev Med | 2013 | https://conductscience.org/library/papers/23072577 | PubMed |
| 11 | 6205804 | Glomerular deposition and serum levels of complement control proteins in patients with IgA nephropathy. | Clin Nephrol | 1984 | https://conductscience.org/library/papers/6205804 | PubMed |
| 12 | 19230171 | C5b-9 glomerular deposition and tubular alpha3beta1-integrin expression are implicated in the development of chronic lesions and predict renal function outcome in immunoglobulin A nephropathy. | Scand J Urol Nephrol | 2008 | https://conductscience.org/library/papers/19230171 | PubMed |
| 13 | 11231363 | Mass spectrometry proves under-O-glycosylation of glomerular IgA1 in IgA nephropathy. | Kidney Int | 2001 | https://conductscience.org/library/papers/11231363 | PubMed |
| 14 | 3586493 | Complement activation in IgA nephropathy. | Kidney Int | 1987 | https://conductscience.org/library/papers/3586493 | PubMed |
| 15 | 11791795 | Inherited factor H dysfunction and complement-associated glomerulonephritis in renal grafts of first and second transplantations. | Clin Transplant | 2001 | https://conductscience.org/library/papers/11791795 | PubMed |
Cited by60
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 96 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42488643 | Case report: Sequential complement inhibition and BAFF/APRIL blockade in progressive IgA nephropathy and IgA vasculitis nephritis: a report of two cases. | Front Immunol | 2026 | https://conductscience.org/library/papers/42488643 | PubMed |
| 41788457 | Immunoglobulin A Nephropathy With Associated Thrombotic Microangiopathy: Biopsy and Clinical Case Series. | Clin Med Insights Case Rep | 2026 | https://conductscience.org/library/papers/41788457 | PubMed |
| 41714421 | Complement and kidney diseases: unlocking the opportunity of targeted treatments for glomerular diseases, including IgA nephropathy. | Pediatr Nephrol | 2026 | https://conductscience.org/library/papers/41714421 | PubMed |
| 41266601 | IgA nephropathy new therapies: from data in adults to application in children. | Pediatr Nephrol | 2026 | https://conductscience.org/library/papers/41266601 | PubMed |
| 41111558 | The Complement System: An Important New Therapeutic Target in IgA Nephropathy. | Glomerular Dis | 2025 | https://conductscience.org/library/papers/41111558 | PubMed |
| 40808688 | Opportunities and challenges in the treatment of IgA nephropathy. | Front Pharmacol | 2025 | https://conductscience.org/library/papers/40808688 | PubMed |
| 39968279 | The road ahead: emerging therapies for primary IgA nephropathy. | Front Nephrol | 2025 | https://conductscience.org/library/papers/39968279 | PubMed |
| 39188719 | Contemporary review of IgA nephropathy. | Front Immunol | 2024 | https://conductscience.org/library/papers/39188719 | PubMed |
| 38777962 | Drugs in Development to Treat IgA Nephropathy. | Drugs | 2024 | https://conductscience.org/library/papers/38777962 | PubMed |
| 38344730 | Systematic Review of the Link Between Oxford MEST-C Classification and Complement Activation in IgA Nephropathy. | Kidney Int Rep | 2024 | https://conductscience.org/library/papers/38344730 | PubMed |
| 38053977 | Targeting complement in IgA nephropathy. | Clin Kidney J | 2023 | https://conductscience.org/library/papers/38053977 | PubMed |
| 37889398 | Clinical advances in immunotherapy for immune-mediated glomerular diseases. | Clin Exp Med | 2023 | https://conductscience.org/library/papers/37889398 | PubMed |
| 37747686 | Current Understanding of Complement Proteins as Therapeutic Targets for the Treatment of Immunoglobulin A Nephropathy. | Drugs | 2023 | https://conductscience.org/library/papers/37747686 | PubMed |
| 37705895 | Challenges in IgA Nephropathy Management: An Era of Complement Inhibition. | Kidney Int Rep | 2023 | https://conductscience.org/library/papers/37705895 | PubMed |
| 37576817 | A bibliometric analysis of complement in IgA nephropathy from 1991 to 2022. | Front Pharmacol | 2023 | https://conductscience.org/library/papers/37576817 | PubMed |
| 37398689 | Immune abnormalities in IgA nephropathy. | Clin Kidney J | 2023 | https://conductscience.org/library/papers/37398689 | PubMed |
| 37240105 | Therapeutic Potential of Targeting Complement C5a Receptors in Diabetic Kidney Disease. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/37240105 | PubMed |
| 37216524 | Germline C1GALT1C1 mutation causes a multisystem chaperonopathy. | Proc Natl Acad Sci U S A | 2023 | https://conductscience.org/library/papers/37216524 | PubMed |
| 36241249 | [Efficacy of plasma exchange in severe crescentic IgA nephropathy: A multicentered, cohort study]. | Beijing Da Xue Xue Bao Yi Xue Ban | 2022 | https://conductscience.org/library/papers/36241249 | PubMed |
| 35757129 | Hypocomplementemic Atypical IgA Vasculitis: A Case Report. | Front Pediatr | 2022 | https://conductscience.org/library/papers/35757129 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| IGHA1 | 3493 | PubTator's text mining | https://conductscience.org/library/genes/3493 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/24924752
GET https://conductscience.org/api/papers/v1/24924752/cited_by?page=2